William Blair analyst Myles Minter initiates coverage on Karuna Therapeutics Inc. (NASDAQ: KRTX) with an Outperform rating and fair value ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE